- IBDEI2L0 ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,41202,1,3,0)
- ;;=3^DM Type 1 w/ Unspec Compl
- ;;^UTILITY(U,$J,358.3,41202,1,4,0)
- ;;=4^E10.8
- ;;^UTILITY(U,$J,358.3,41202,2)
- ;;=^5002625
- ;;^UTILITY(U,$J,358.3,41203,0)
- ;;=E10.9^^152^2029^34
- ;;^UTILITY(U,$J,358.3,41203,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41203,1,3,0)
- ;;=3^DM Type 1 w/o Compl
- ;;^UTILITY(U,$J,358.3,41203,1,4,0)
- ;;=4^E10.9
- ;;^UTILITY(U,$J,358.3,41203,2)
- ;;=^5002626
- ;;^UTILITY(U,$J,358.3,41204,0)
- ;;=E10.620^^152^2029^5
- ;;^UTILITY(U,$J,358.3,41204,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41204,1,3,0)
- ;;=3^DM Type 1 w/ Diab Dermatitis
- ;;^UTILITY(U,$J,358.3,41204,1,4,0)
- ;;=4^E10.620
- ;;^UTILITY(U,$J,358.3,41204,2)
- ;;=^5002615
- ;;^UTILITY(U,$J,358.3,41205,0)
- ;;=E10.36^^152^2029^4
- ;;^UTILITY(U,$J,358.3,41205,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41205,1,3,0)
- ;;=3^DM Type 1 w/ Diab Cataract
- ;;^UTILITY(U,$J,358.3,41205,1,4,0)
- ;;=4^E10.36
- ;;^UTILITY(U,$J,358.3,41205,2)
- ;;=^5002602
- ;;^UTILITY(U,$J,358.3,41206,0)
- ;;=E10.621^^152^2029^6
- ;;^UTILITY(U,$J,358.3,41206,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41206,1,3,0)
- ;;=3^DM Type 1 w/ Diab Foot Ulcer
- ;;^UTILITY(U,$J,358.3,41206,1,4,0)
- ;;=4^E10.621
- ;;^UTILITY(U,$J,358.3,41206,2)
- ;;=^5002616
- ;;^UTILITY(U,$J,358.3,41207,0)
- ;;=E10.622^^152^2029^28
- ;;^UTILITY(U,$J,358.3,41207,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41207,1,3,0)
- ;;=3^DM Type 1 w/ Oth Skin Ulcer
- ;;^UTILITY(U,$J,358.3,41207,1,4,0)
- ;;=4^E10.622
- ;;^UTILITY(U,$J,358.3,41207,2)
- ;;=^5002617
- ;;^UTILITY(U,$J,358.3,41208,0)
- ;;=E10.51^^152^2029^32
- ;;^UTILITY(U,$J,358.3,41208,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41208,1,3,0)
- ;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
- ;;^UTILITY(U,$J,358.3,41208,1,4,0)
- ;;=4^E10.51
- ;;^UTILITY(U,$J,358.3,41208,2)
- ;;=^5002610
- ;;^UTILITY(U,$J,358.3,41209,0)
- ;;=E10.52^^152^2029^31
- ;;^UTILITY(U,$J,358.3,41209,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41209,1,3,0)
- ;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
- ;;^UTILITY(U,$J,358.3,41209,1,4,0)
- ;;=4^E10.52
- ;;^UTILITY(U,$J,358.3,41209,2)
- ;;=^5002611
- ;;^UTILITY(U,$J,358.3,41210,0)
- ;;=E11.00^^152^2030^19
- ;;^UTILITY(U,$J,358.3,41210,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41210,1,3,0)
- ;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
- ;;^UTILITY(U,$J,358.3,41210,1,4,0)
- ;;=4^E11.00
- ;;^UTILITY(U,$J,358.3,41210,2)
- ;;=^5002627
- ;;^UTILITY(U,$J,358.3,41211,0)
- ;;=E11.01^^152^2030^18
- ;;^UTILITY(U,$J,358.3,41211,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41211,1,3,0)
- ;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
- ;;^UTILITY(U,$J,358.3,41211,1,4,0)
- ;;=4^E11.01
- ;;^UTILITY(U,$J,358.3,41211,2)
- ;;=^5002628
- ;;^UTILITY(U,$J,358.3,41212,0)
- ;;=E11.21^^152^2030^7
- ;;^UTILITY(U,$J,358.3,41212,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41212,1,3,0)
- ;;=3^DM Type 2 w/ Diab Nephropathy
- ;;^UTILITY(U,$J,358.3,41212,1,4,0)
- ;;=4^E11.21
- ;;^UTILITY(U,$J,358.3,41212,2)
- ;;=^5002629
- ;;^UTILITY(U,$J,358.3,41213,0)
- ;;=E11.22^^152^2030^3
- ;;^UTILITY(U,$J,358.3,41213,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41213,1,3,0)
- ;;=3^DM Type 2 w/ Diab CKD
- ;;^UTILITY(U,$J,358.3,41213,1,4,0)
- ;;=4^E11.22
- ;;^UTILITY(U,$J,358.3,41213,2)
- ;;=^5002630
- ;;^UTILITY(U,$J,358.3,41214,0)
- ;;=E11.39^^152^2030^28
- ;;^UTILITY(U,$J,358.3,41214,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41214,1,3,0)
- ;;=3^DM Type 2 w/ Oth Diab Ophth Compl
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2L0 3754 printed Feb 18, 2025@23:57:14 Page 2
- IBDEI2L0 ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,41202,1,3,0)
- +2 ;;=3^DM Type 1 w/ Unspec Compl
- +3 ;;^UTILITY(U,$J,358.3,41202,1,4,0)
- +4 ;;=4^E10.8
- +5 ;;^UTILITY(U,$J,358.3,41202,2)
- +6 ;;=^5002625
- +7 ;;^UTILITY(U,$J,358.3,41203,0)
- +8 ;;=E10.9^^152^2029^34
- +9 ;;^UTILITY(U,$J,358.3,41203,1,0)
- +10 ;;=^358.31IA^4^2
- +11 ;;^UTILITY(U,$J,358.3,41203,1,3,0)
- +12 ;;=3^DM Type 1 w/o Compl
- +13 ;;^UTILITY(U,$J,358.3,41203,1,4,0)
- +14 ;;=4^E10.9
- +15 ;;^UTILITY(U,$J,358.3,41203,2)
- +16 ;;=^5002626
- +17 ;;^UTILITY(U,$J,358.3,41204,0)
- +18 ;;=E10.620^^152^2029^5
- +19 ;;^UTILITY(U,$J,358.3,41204,1,0)
- +20 ;;=^358.31IA^4^2
- +21 ;;^UTILITY(U,$J,358.3,41204,1,3,0)
- +22 ;;=3^DM Type 1 w/ Diab Dermatitis
- +23 ;;^UTILITY(U,$J,358.3,41204,1,4,0)
- +24 ;;=4^E10.620
- +25 ;;^UTILITY(U,$J,358.3,41204,2)
- +26 ;;=^5002615
- +27 ;;^UTILITY(U,$J,358.3,41205,0)
- +28 ;;=E10.36^^152^2029^4
- +29 ;;^UTILITY(U,$J,358.3,41205,1,0)
- +30 ;;=^358.31IA^4^2
- +31 ;;^UTILITY(U,$J,358.3,41205,1,3,0)
- +32 ;;=3^DM Type 1 w/ Diab Cataract
- +33 ;;^UTILITY(U,$J,358.3,41205,1,4,0)
- +34 ;;=4^E10.36
- +35 ;;^UTILITY(U,$J,358.3,41205,2)
- +36 ;;=^5002602
- +37 ;;^UTILITY(U,$J,358.3,41206,0)
- +38 ;;=E10.621^^152^2029^6
- +39 ;;^UTILITY(U,$J,358.3,41206,1,0)
- +40 ;;=^358.31IA^4^2
- +41 ;;^UTILITY(U,$J,358.3,41206,1,3,0)
- +42 ;;=3^DM Type 1 w/ Diab Foot Ulcer
- +43 ;;^UTILITY(U,$J,358.3,41206,1,4,0)
- +44 ;;=4^E10.621
- +45 ;;^UTILITY(U,$J,358.3,41206,2)
- +46 ;;=^5002616
- +47 ;;^UTILITY(U,$J,358.3,41207,0)
- +48 ;;=E10.622^^152^2029^28
- +49 ;;^UTILITY(U,$J,358.3,41207,1,0)
- +50 ;;=^358.31IA^4^2
- +51 ;;^UTILITY(U,$J,358.3,41207,1,3,0)
- +52 ;;=3^DM Type 1 w/ Oth Skin Ulcer
- +53 ;;^UTILITY(U,$J,358.3,41207,1,4,0)
- +54 ;;=4^E10.622
- +55 ;;^UTILITY(U,$J,358.3,41207,2)
- +56 ;;=^5002617
- +57 ;;^UTILITY(U,$J,358.3,41208,0)
- +58 ;;=E10.51^^152^2029^32
- +59 ;;^UTILITY(U,$J,358.3,41208,1,0)
- +60 ;;=^358.31IA^4^2
- +61 ;;^UTILITY(U,$J,358.3,41208,1,3,0)
- +62 ;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
- +63 ;;^UTILITY(U,$J,358.3,41208,1,4,0)
- +64 ;;=4^E10.51
- +65 ;;^UTILITY(U,$J,358.3,41208,2)
- +66 ;;=^5002610
- +67 ;;^UTILITY(U,$J,358.3,41209,0)
- +68 ;;=E10.52^^152^2029^31
- +69 ;;^UTILITY(U,$J,358.3,41209,1,0)
- +70 ;;=^358.31IA^4^2
- +71 ;;^UTILITY(U,$J,358.3,41209,1,3,0)
- +72 ;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
- +73 ;;^UTILITY(U,$J,358.3,41209,1,4,0)
- +74 ;;=4^E10.52
- +75 ;;^UTILITY(U,$J,358.3,41209,2)
- +76 ;;=^5002611
- +77 ;;^UTILITY(U,$J,358.3,41210,0)
- +78 ;;=E11.00^^152^2030^19
- +79 ;;^UTILITY(U,$J,358.3,41210,1,0)
- +80 ;;=^358.31IA^4^2
- +81 ;;^UTILITY(U,$J,358.3,41210,1,3,0)
- +82 ;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
- +83 ;;^UTILITY(U,$J,358.3,41210,1,4,0)
- +84 ;;=4^E11.00
- +85 ;;^UTILITY(U,$J,358.3,41210,2)
- +86 ;;=^5002627
- +87 ;;^UTILITY(U,$J,358.3,41211,0)
- +88 ;;=E11.01^^152^2030^18
- +89 ;;^UTILITY(U,$J,358.3,41211,1,0)
- +90 ;;=^358.31IA^4^2
- +91 ;;^UTILITY(U,$J,358.3,41211,1,3,0)
- +92 ;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
- +93 ;;^UTILITY(U,$J,358.3,41211,1,4,0)
- +94 ;;=4^E11.01
- +95 ;;^UTILITY(U,$J,358.3,41211,2)
- +96 ;;=^5002628
- +97 ;;^UTILITY(U,$J,358.3,41212,0)
- +98 ;;=E11.21^^152^2030^7
- +99 ;;^UTILITY(U,$J,358.3,41212,1,0)
- +100 ;;=^358.31IA^4^2
- +101 ;;^UTILITY(U,$J,358.3,41212,1,3,0)
- +102 ;;=3^DM Type 2 w/ Diab Nephropathy
- +103 ;;^UTILITY(U,$J,358.3,41212,1,4,0)
- +104 ;;=4^E11.21
- +105 ;;^UTILITY(U,$J,358.3,41212,2)
- +106 ;;=^5002629
- +107 ;;^UTILITY(U,$J,358.3,41213,0)
- +108 ;;=E11.22^^152^2030^3
- +109 ;;^UTILITY(U,$J,358.3,41213,1,0)
- +110 ;;=^358.31IA^4^2
- +111 ;;^UTILITY(U,$J,358.3,41213,1,3,0)
- +112 ;;=3^DM Type 2 w/ Diab CKD
- +113 ;;^UTILITY(U,$J,358.3,41213,1,4,0)
- +114 ;;=4^E11.22
- +115 ;;^UTILITY(U,$J,358.3,41213,2)
- +116 ;;=^5002630
- +117 ;;^UTILITY(U,$J,358.3,41214,0)
- +118 ;;=E11.39^^152^2030^28
- +119 ;;^UTILITY(U,$J,358.3,41214,1,0)
- +120 ;;=^358.31IA^4^2
- +121 ;;^UTILITY(U,$J,358.3,41214,1,3,0)
- +122 ;;=3^DM Type 2 w/ Oth Diab Ophth Compl